310 related articles for article (PubMed ID: 24891168)
1. Initial radioiodine administration: when to use it and how to select the dose.
Esposito G
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
Pryma DA; Mandel SJ
J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
[TBL] [Abstract][Full Text] [Related]
3. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
[No Abstract] [Full Text] [Related]
4. Dosimetry and thyroid cancer: the individual dosage of radioiodine.
Lassmann M; Reiners C; Luster M
Endocr Relat Cancer; 2010 Sep; 17(3):R161-72. PubMed ID: 20448022
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.
Padma S; Sundaram PS
J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519
[TBL] [Abstract][Full Text] [Related]
6. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine in the treatment of thyroid cancer.
Van Nostrand D; Wartofsky L
Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
[TBL] [Abstract][Full Text] [Related]
8. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
Mattsson S; Johansson L; Jönsson H; Nosslin B
Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
[TBL] [Abstract][Full Text] [Related]
9. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
10. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
Janisch A; Altenbrunn HJ; Markwardt J
Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
[No Abstract] [Full Text] [Related]
11. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
12. [Possible sequelae of the action of radioactive iodine in man].
Il'in LA; Arkhangel'skaia GV
Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
[No Abstract] [Full Text] [Related]
13. Radioiodine therapy of thyroid autonomy.
Reiners C; Schneider P
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
[TBL] [Abstract][Full Text] [Related]
14. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
Börner AR; Müller-Gärtner HW
Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
[TBL] [Abstract][Full Text] [Related]
15. Absence of bone marrow toxicity in elderly patients treated with recombinant human thyroid-stimulating hormone and empirically dosed radioiodine for thyroid cancer.
Amdur RJ; Dan T; Mazzaferri E
Am J Clin Oncol; 2013 Aug; 36(4):348-53. PubMed ID: 22547013
[TBL] [Abstract][Full Text] [Related]
16. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
; Cooper DS; Doherty GM; Haugen BR; Kloos RT; Lee SL; Mandel SJ; Mazzaferri EL; McIver B; Pacini F; Schlumberger M; Sherman SI; Steward DL; Tuttle RM
Thyroid; 2009 Nov; 19(11):1167-214. PubMed ID: 19860577
[TBL] [Abstract][Full Text] [Related]
17. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer.
Johansen K; Woodhouse NJ; Odugbesan O
J Nucl Med; 1991 Feb; 32(2):252-4. PubMed ID: 1992028
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
20. [Radioiodine therapy in differentiated thyroid gland carcinoma].
Schicha H; Dietlein M
Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
